Current advance of nanotechnology in diagnosis and treatment for malignant tumors

B Wang, S Hu, Y Teng, J Chen, H Wang, Y Xu… - … and Targeted Therapy, 2024 - nature.com
Cancer remains a significant risk to human health. Nanomedicine is a new multidisciplinary
field that is garnering a lot of interest and investigation. Nanomedicine shows great potential …

Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity

RC Gimple, K Yang, ME Halbert, S Agnihotri… - Nature Reviews …, 2022 - nature.com
Malignant brain tumours are complex ecosystems containing neoplastic and stromal
components that generate adaptive and evolutionarily driven aberrant tissues in the central …

Penetrative and sustained drug delivery using injectable hydrogel nanocomposites for postsurgical brain tumor treatment

T Kang, GD Cha, OK Park, HR Cho, M Kim, J Lee… - ACS …, 2023 - ACS Publications
Postsurgical treatment of glioblastoma multiforme (GBM) by systemic chemotherapy and
radiotherapy is often inefficient. Tumor cells infiltrating deeply into the brain parenchyma are …

Three-dimensional bioprinted glioblastoma microenvironments model cellular dependencies and immune interactions

M Tang, Q Xie, RC Gimple, Z Zhong, T Tam, J Tian… - Cell research, 2020 - nature.com
Brain tumors are dynamic complex ecosystems with multiple cell types. To model the brain
tumor microenvironment in a reproducible and scalable system, we developed a rapid three …

Exploration and functionalization of M1-macrophage extracellular vesicles for effective accumulation in glioblastoma and strong synergistic therapeutic effects

X Wang, H Ding, Z Li, Y Peng, H Tan, C Wang… - … and Targeted Therapy, 2022 - nature.com
Glioblastoma multiforme (GBM) is a highly aggressive brain tumor with an extremely low
survival rate. New and effective approaches for treatment are therefore urgently needed …

Biomaterials and 3D bioprinting strategies to model glioblastoma and the blood–brain barrier

M Tang, JN Rich, S Chen - Advanced Materials, 2021 - Wiley Online Library
Glioblastoma (GBM) is the most prevalent and lethal adult primary central nervous system
cancer. An immunosuppresive and highly heterogeneous tumor microenvironment …

Targeting the tumor biophysical microenvironment to reduce resistance to immunotherapy

T Zhang, Y Jia, Y Yu, B Zhang, F Xu, H Guo - Advanced drug delivery …, 2022 - Elsevier
Immunotherapy based on immune checkpoint inhibitors has evolved into a new pillar of
cancer treatment in clinics, but dealing with treatment resistance (either primary or acquired) …

Rationally designed drug delivery systems for the local treatment of resected glioblastoma

C Bastiancich, A Malfanti, V Préat, R Rahman - Advanced drug delivery …, 2021 - Elsevier
Glioblastoma (GBM) is a particularly aggressive brain cancer associated with high
recurrence and poor prognosis. The standard of care, surgical resection followed by …

Organ-On-A-Chip in vitro Models of the Brain and the Blood-Brain Barrier and Their Value to Study the Microbiota-Gut-Brain Axis in Neurodegeneration

I Raimondi, L Izzo, M Tunesi, M Comar… - … in bioengineering and …, 2020 - frontiersin.org
We are accumulating evidence that intestinal microflora, collectively named gut microbiota,
can alter brain pathophysiology, but researchers have just begun to discover the …

Blood–brain barrier (BBB)-on-a-chip: a promising breakthrough in brain disease research

B Peng, S Hao, Z Tong, H Bai, S Pan, KL Lim, L Li… - Lab on a Chip, 2022 - pubs.rsc.org
The blood–brain barrier (BBB) represents a key challenge in developing brain-penetrating
therapeutic molecules. BBB dysfunction is also associated with the onset and progression of …